Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BTK inhibitors
Fierce Biotech
FDA shares CRL for Sanofi MS drug mere weeks after rebuff
Less than two weeks after rejecting Sanofi’s investigational MS drug, the FDA has shared the CRL, citing both efficacy and safety concerns.
Gabrielle Masson
Jan 6, 2026 4:30am
Why Lilly is betting on 2nd-line CLL despite 1st-line wins
Dec 9, 2025 7:30am
Lilly's BTK inhibitor Jaypirca wins lymphoma label expansion
Dec 3, 2025 8:25am
Zenas gains MS hopeful in $2B deal with China's InnoCare
Oct 8, 2025 11:50am
AbbVie, BeOne end BTK inhibitor patent fight
Oct 2, 2025 10:29am
Novartis' BTK inhibitor wins FDA approval in chronic hives
Sep 30, 2025 6:40pm
